AHF Podcast

Anterior Hip Foundation

The AHF Podcast features thoughtful conversations about orthopedic surgery, outcomes, and clinical decision-making, with a particular focus on hip surgery and related innovation.Produced by the Anterior Hip Foundation, the podcast brings together surgeons, researchers, and clinical leaders to examine how evidence, experience, and real-world practice intersect. Episodes explore what the data actually shows, where assumptions break down, and how clinicians navigate uncertainty in daily practice.This podcast is intended for orthopedic surgeons, trainees, and medically literate clinicians who value nuanced discussion, critical thinking, and honest examination of what improves patient care.

  1. 6d ago

    Complex primary THA with AA (S+N Surgeon Roundtable)

    Send us Fan Mail What do you do the moment a calcar crack appears? Where does the cup go when the spine won't move? And which complex primary belongs in an ASC — and which one absolutely doesn't? This episode launches a six-part surgeon roundtable series recorded in partnership with Smith+Nephew — peer-to-peer conversations aimed at one thing: practical, reproducible techniques you can take back to your operating room. First up, the complex primary total hip: severe dysplasia, post-traumatic anatomy, obesity, osteoporosis, and Dorr A femurs — the hips where the margin for error shrinks and the plan gets tested. Three guests join Joe Schwab: Dr. Jessica Hooper, who leads an outpatient joint program and knows what complex work can be done safely in an ASC; Dr. Stephen Duncan, who operates from hip preservation through revision and sees exactly which traps in a primary set up the revision that follows; and Dr. Chad Watts, a high-volume hip surgeon focused on making every step repeatable. The conversation gets concrete fast: structured planning two weeks out (CT for version, long-leg standing films — "hope is not a plan"), go/no-go criteria for the anterior approach, the low-small-medial cup strategy in dysplasia versus the oversized-cup trap, locking-screw cups in deficient bone, why triple-taper stems changed the fracture picture, automated impaction, the full decision framework for an intraoperative calcar crack, controlled medialization under fluoro (and the case for sharp reamers), where each surgeon falls on the spinopelvic spectrum, when dual mobility earns its place, and what changes between ASC and hospital workflows — including how to teach plan B and plan C so, as Dr. Duncan puts it, "plan C should not be chaos." ⏱️ Chapters: 00:00 A new roundtable series 02:06 Keeping high-risk primaries safe in an ASC 02:59 The step Chad Watts never skips 04:08 The traps that set up tomorrow's revision 05:05 What dysplasia and post-trauma change in the plan 07:39 When not to go anterior 09:00 Non-negotiables: templating, version, limb length 10:25 "Hope is not a plan": CT and long-leg films 11:41 Restoring the hip center without over-lengthening 15:09 A preservation mindset in dysplasia 16:51 Dorr A femurs: exposure and broaching principles 18:17 Where fractures happen — and how to prevent them 19:57 Intraoperative cues to slow down 23:00 Stem design, triple tapers, and automated impaction 28:18 Calcar crack: the decision framework 34:33 Keeping the room calm and controlled 35:39 Avoiding over-reaming in compromised bone 37:21 Hitting narrow cup targets under fluoro 40:13 How much does spinopelvic mobility matter? 44:01 Where dual mobility earns its place 46:24 Reproducible workflows: ASC vs. hospital 50:23 "Plan C should not be chaos" 51:48 Closing advice: mindset shifts and patient selection Listen to the AHF Podcast on your preferred platform: Buzzsprout: https://ahfpodcast.buzzsprout.com Apple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487 Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHc LinkedIn: https://www.linkedin.com/showcase/ahf-podcast YouTube: https://www.youtube.com/@anteriorhipfoundation Homepage: https://anteriorhipfoundation.com This episode was recorded in partnership with Smith+Nephew — Life Unlimited. Learn more at https://www.smith-nephew.com This podcast is intended for educational and informational purposes only. The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion. #AnteriorHipFoundation #AHFPodcast #TotalHipArthroplasty #THA #AnteriorApproach #HipReplacement #Dysplasia #CalcarFracture #DorrA #DualMobility #SpinopelvicMobility #OutpatientSurgery #SmithNephew #OrthopedicSurgery Smith+NephewWe design and manufacture technology that takes the limits off living.Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.

  2. Jul 24

    From Idea to Market: Ep 12 - From Here, It's Yours

    Send us Fan Mail In the finale of From Idea to Market, the surgeons, engineers, founders, attorneys, and investors who lived every stage of medical device innovation look back and answer one question: what do they wish they had known from the start? Across this series, one pattern kept surfacing: innovation doesn't begin with a business plan. It begins with a clinical problem someone can't let go — a resident watching a procedure that felt inadequate and carrying that feeling for twenty-five years, or a physician-turned-founder who couldn't stop thinking about a patient who lacked what she needed. In this closing episode, Robert Cohen reflects on four decades in med tech and the permission to say "I don't know." Alexander Sah describes the emotional rollercoaster of introducing new technology — and knowing when to abandon an idea. Charlie DeCook and Simon Mifsud explain why the idea itself is never the advantage. Charles Lawrie distills the whole journey into a playbook: start with a problem you live, build with people who know what you don't, think big but execute small. Leo Whiteside talks about protecting intellectual property, standing alone on panels, and why the work is "a very joyful thing to do." Emily Ast and Marie-Isabelle Batthyány close with the tests that matter: the right team, the family at the dinner table, and a real need — not an imagined one. If there's a problem in your practice that keeps coming back to you, this episode is the series' parting argument for taking it seriously. From here, it's yours. ⏱️ Chapters: 00:00 Introduction: what the series taught us about innovators 02:54 The problem you can't let go: where innovation begins 07:13 What innovation demands: vulnerability and listening 09:42 The emotional rollercoaster of device development 11:29 Why the idea is not the advantage: iteration and teams 13:55 Charles Lawrie's playbook: start with a problem you live 16:52 Leo Whiteside on opposition, IP, and the joy of the work 19:04 Legal, financial, and family support for innovators 20:33 Real needs, not imagined ones: the test of every device 22:03 From here, it's yours: a challenge to the next innovator Listen to the AHF Podcast on your preferred platform: Buzzsprout: https://ahfpodcast.buzzsprout.com Apple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487 Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHc LinkedIn: https://www.linkedin.com/showcase/ahf-podcast YouTube: https://www.youtube.com/@anteriorhipfoundation Homepage: https://anteriorhipfoundation.com This podcast is intended for educational and informational purposes only. The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion. #AnteriorHipFoundation #AHFPodcast #MedTech #MedicalDevices #HealthcareInnovation #OrthopedicSurgery #SurgeonEntrepreneur #DeviceDevelopment #MedicalInnovation #FromIdeaToMarket #StartupAdvice #HipReplacement

  3. Jul 17

    From Idea to Market: Ep 11 - Built to Last or Built to Sell?

    Send us Fan Mail Is your med tech company built to last, or built to sell? Voices from inside Stryker, XRSynergies, FIOS Health, and physician contract law explain why exit strategy is a design choice founders make on day one — whether they realize it or not. In 2024, med tech M&A reached a record $474 billion in global transaction value. For most successful device startups, the path to broad patient reach runs through acquisition — and that reality shapes how experienced founders structure their companies from the moment of incorporation. Corporate form, consulting agreements, equity design, and quality systems all encode an implied destination long before an acquirer ever calls. Robert Cohen (VP of Innovation & Technology, Stryker Orthopedics) describes how acquisition conversations actually unfold — why the clinical case comes before any discussion of cost of goods or time to market, and how incorporating as a C corporation from day one made his second company's acquisition by Mako Surgical dramatically easier. Marie-Isabelle Batthyány (founder & CEO, XRSynergies) explains building a company that is "easy to take over," from phantom share programs to diligence-ready quality management. Attorney Emily Ast unpacks the shift from long royalty streams toward milestone-based deal structures, and Charles Lawrie (co-founder, FIOS Health) makes the case for clinical validation as the founder's contribution, with commercial scaling left to the acquirer. Whether you're a surgeon with a device idea, a founder weighing an LLC against a C corporation, or a clinician curious how acquisitions preserve or lose the clinical knowledge behind a product, this episode maps the decisions that determine what your company becomes. ⏱️ Chapters: 00:00 Introduction: exit as a design choice, not a finish line 03:00 Meet the founders, acquirers, and attorneys 05:06 Early structural choices that define what a company becomes 06:04 What a med tech acquirer is actually buying 08:12 How acquisition conversations start: the clinical case first 10:24 Structuring a startup to be acquisition-ready 12:57 Path dependency: early decisions that get expensive to reverse 14:17 Why a C corporation from day one speeds diligence 16:31 Royalties vs milestone payments in med tech deals 19:34 Why acquisitions underperform: knowledge transfer and retention 24:18 Building to sell: clinical validation vs commercial scale Listen to the AHF Podcast on your preferred platform: Buzzsprout: https://ahfpodcast.buzzsprout.com Apple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487 Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHc LinkedIn: https://www.linkedin.com/showcase/ahf-podcast YouTube: https://www.youtube.com/@anteriorhipfoundation Homepage: https://anteriorhipfoundation.com This podcast is intended for educational and informational purposes only. The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion. #AnteriorHipFoundation #AHFPodcast #MedTech #MedicalDevices #MedTechAcquisitions #ExitStrategy #MedicalDeviceStartup #OrthopedicSurgery #HealthcareInnovation #DeviceDevelopment #FromIdeaToMarket #Stryker

  4. Jul 3

    Operation FUBAR: One-in-Six-Million Bone

    Send us Fan Mail What do you do when the greater trochanter shears off during a routine hip replacement — and the bone is too soft to hold a screw? Dr. Jeff Barry of UCSF walks through two intraoperative disasters in the same patient, and how he salvaged both. Jeff Barry, who directs the Hip and Knee Arthroplasty Fellowship at UCSF and co-directs the Arthroplasty for the Modern Surgeon course, joins Joe Schwab for an Operation FUBAR case review most surgeons will recognize with a wince: a frail 75-year-old retired nurse with a rapidly collapsing hip, leukemia, low platelets, and osteoporosis so severe her DEXA T-score came back at -5.1 — statistically about one in six million. On the first side, the trochanter shears off during a femoral exposure Barry has performed thousands of times. On the second side a year later — after a missed femoral neck fracture — a gently tapped multi-hole cup punches straight through the medial wall. Barry talks through the decision-making in both moments: when less is more, how locking-screw revision cups can function as an internal cage, and why the "trap side" of a case is often the one you weren't worried about. The conversation goes beyond technique into how surgeons process intraoperative complications — stepping back from the wound to game-plan, communicating with anesthesia before cementing in a pulmonary patient, protecting the next case on the schedule, and the value of a "confessional" text thread with trusted colleagues. For arthroplasty surgeons, fellows, and residents, this is an honest look at what severely osteoporotic bone can do to even a well-planned primary. ⏱️ Chapters: 00:00 Introduction and guest background 01:31 Frail elderly patient with a rapidly collapsing hip 03:37 Planning a cemented hip in severe osteoporosis 06:21 Greater trochanter shears off during femoral exposure 08:00 How surgeons react when a case goes wrong 13:27 What a T-score of -5.1 means for hip surgery 14:42 Missed femoral neck fracture in the opposite hip 16:44 Acetabular cup punches through the medial wall 19:21 Salvaging a failed cup with locking screws 24:45 Managing pelvic discontinuity as the rescue surgeon 28:46 Knowing when to call for help in the OR 33:33 Teaching trainees through intraoperative complications 40:12 Debriefing and the surgeon confessional after complications Listen to the AHF Podcast on your preferred platform: Buzzsprout: https://ahfpodcast.buzzsprout.com Apple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487 Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHc LinkedIn: https://www.linkedin.com/showcase/ahf-podcast YouTube: https://www.youtube.com/@anteriorhipfoundation Homepage: https://anteriorhipfoundation.com This podcast is intended for educational and informational purposes only. The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion. #AnteriorHipFoundation #AHFPodcast #TotalHipArthroplasty #THA #AnteriorApproach #HipReplacement #Osteoporosis #RevisionHipSurgery #FemoralNeckFracture #PeriprostheticFracture #CementedStem #PelvicDiscontinuity #JeffBarry #OrthopedicSurgery

  5. Jun 26

    Mapping How the World Really Does Hip Replacement

    Send us Fan Mail How does hip replacement practice really differ from one country to the next? Researcher Irrum Afzal joins the AHF Podcast to discuss the Global Arthroplasty Practice Survey (GAPS) — the first effort to map how surgeons worldwide actually perform total hip replacement. Despite roughly seventy years of modern hip replacement, there's still no global consensus on the fundamentals — surgical approach, fixation, bearing surface, or the perioperative pathway. National joint registries capture some of this, but their coverage and data quality vary widely, and many countries have no registry at all. The result is that we know surprisingly little about how the operation is actually performed around the world. Irrum Afzal, a researcher at Imperial College London and a digital health transformation specialist, is working to close that gap. Co-led with Professor Richard Field, GAPS asks surgeons of every volume and career stage to describe their real preoperative, intraoperative, and postoperative practice. It takes under ten minutes, covers the full patient journey, and is built to feed a long-term dataset that machine learning can eventually turn into research priorities and a working global consensus. Along the way, Irrum explains how her study on the accuracy of National Joint Registry revision data shaped her thinking about data quality, why anterior approach adoption ranges from around 1% in the UK to 56% in the US, and what surgeon-reported practice data can add to what registries already collect. If you perform hip replacement, your answers help build the first real worldwide picture of the field — and the survey is open through 30 June. Take the Survey Here: https://tinyurl.com/GAPSHIPS Visit the Working Group: https://www.globalarthroplastypractice.com/ ⏱️ Chapters: 00:00 Introduction and guest background 01:40 How a public health researcher moved into orthopaedics 02:48 Why hip revision registry data is often inaccurate 04:46 What the Global Arthroplasty Practice Survey measures 07:14 Why hip replacement practice still varies worldwide 08:42 Who runs GAPS and how to join the working group 10:08 Why surgeons should take the survey and what they gain 13:18 Using AI to turn survey responses into research priorities 14:01 How many responses GAPS needs and the June 30th deadline 16:50 What success looks like and sharing data with registries 19:05 Presenting GAPS results at the European Anterior Hip Meeting Listen to the AHF Podcast on your preferred platform: Buzzsprout: https://ahfpodcast.buzzsprout.com Apple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487 Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHc LinkedIn: https://www.linkedin.com/showcase/ahf-podcast YouTube: https://www.youtube.com/@anteriorhipfoundation Homepage: https://anteriorhipfoundation.com This podcast is intended for educational and informational purposes only. The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion. #AnteriorHipFoundation #AHFPodcast #HipReplacement #TotalHipArthroplasty #THA #AnteriorApproach #JointRegistry #NationalJointRegistry #OrthopaedicResearch #GAPS #IrrumAfzal #HipRevision #ArthroplastyData

  6. May 22

    From Idea to Market: Ep 10 - What Breaks at Scale

    Send us Fan Mail What real-world use reveals about a medical device that no clinical trial ever could — and why the most dangerous moment in med tech innovation often comes after success, not before. A conversation about the fatigue failures, reimbursement gaps, and feedback breakdowns that surface only at scale. For ten episodes, the From Idea to Market series has followed medical innovation through every threshold an idea must survive — the first clinical insight, the years of iteration, the funding rounds, the regulatory climb, the investor's decision room. Episode 10 asks what happens after all of that succeeds. When a product is working, when demand is building, when expectations have risen, what new vulnerabilities does that very success create? Joe Schwab is joined by four voices who have lived this stage from different positions. Jared Foran is an orthopaedic surgeon in Denver and co-founder and chief scientific officer of Forcast Orthopedics. Doug Fairbanks is the president, CEO, and board member at VISIE Inc. Charlie DeCook is the president of Total Joint Specialists, a 17-surgeon group in Atlanta. Robert Cohen is the vice president of innovation and technology for Stryker's orthopaedic group, with four decades of watching the commercial environment for med tech innovation shift around him. The episode works through three questions: what does real-world use reveal that no development program ever can, which structural and commercial weaknesses surface only at scale, and how do teams build the organizational discipline to act on what the market tells them. The conversation moves from product iteration after launch, to the second valley of death between regulatory clearance and reimbursement, to the feedback loops inside an organization that determine whether real-world signals reach the people who can act on them. For surgeon-founders, for engineers in med tech, and for anyone trying to understand why so many clinically promising ideas stall after they reach the market, this episode is about what scale actually demands. ⏱️ Chapters: 00:00 What happens to medical devices after they reach the market 02:53 Surgeons and industry leaders who scaled med tech innovations 04:35 The fatigue failure principle applied to medical devices 06:05 What real-world use reveals that clinical trials never can 09:15 Why most med tech products require a major pivot post-launch 11:33 How to sustain commercial momentum after launch 14:32 The second valley of death between clearance and reimbursement 16:13 Inside the new FDA-CMS RAPID coverage pathway 17:36 How reimbursement uncertainty kills good clinical ideas 22:35 Building feedback loops before scale exposes the gaps 25:39 Why launch is the start of development, not the end 30:55 Preview: built to last or built to sell Listen to the AHF Podcast on your preferred platform: Buzzsprout: https://ahfpodcast.buzzsprout.com Apple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487 Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHc LinkedIn: https://www.linkedin.com/showcase/ahf-podcast YouTube: https://www.youtube.com/@anteriorhipfoundation Homepage: https://anteriorhipfoundation.com This podcast is intended for educational and informational purposes only. The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion. #anteriorhipfoundation   #AHFPodcast #MedTech #MedTechInnovation #FromIdeaToMarket #PostMarketSurveillance #MedicalDevices #Reimbursement #FDA #ValleyOfDeath #Stryker #OrthopedicSurgery

  7. May 19

    FITM Extended Interview: Alexander Sah

    Send us Fan Mail Alex Sah on what it actually takes for a practicing surgeon to develop new orthopaedic tools — from first idea to OR adoption. An honest conversation about mentors, mistakes, AI, and knowing when to walk away from a collaboration. Most surgeons spot problems in the OR daily and quietly adapt to the limits of existing tools. Alex Sah, a high-volume hip and knee surgeon in Silicon Valley and Chief Medical Officer at Think Surgical, has chosen instead to engage directly with industry — first as an evaluator, then as an advisor, and eventually as a design partner. In this conversation with Joe Schwab, he walks through how that progression actually works in practice, and why he thinks every surgeon with a good idea owes it to themselves to start the process now rather than later. The discussion gets practical fast. Alex breaks down how to vet an idea with a mentor and a patent search, why timing and portfolio fit can make or break a great concept, how to set milestones that let you walk away gracefully from a stalled collaboration, and why the technologies that succeed are usually the ones that speak for themselves the first time a surgeon uses them. He also shares a small habit with big implications — keeping his OR team blinded when testing new products to neutralize the placebo effect that quietly distorts informal evaluations. The conversation closes on AI's inevitable arrival in orthopaedics, the surgeon's role in shaping it before it gets shaped for us, and the AHF Shark Tank as a live laboratory for the From Idea to Market journey. If you've been sitting on an idea, or wondering whether to take that next call from a device rep with a prototype, this episode is a realistic map of the road ahead. ⏱️ Chapters: 00:00 Introduction and Silicon Valley innovation roots 01:02 Why surgeons should solve problems instead of adapting 03:25 Surgeon roles in product development 04:24 First steps for surgeons with no industry connections 05:41 Turning a clinical idea into a development concept 06:46 Setting milestones and knowing when to walk away 08:01 Lessons from working with Think Surgical 10:50 Evaluating new surgical technology objectively 12:14 Essential advice for first-time surgeon innovators 15:47 Why surgeons must help shape AI in orthopaedics 17:40 Inside the AHF Shark Tank for surgical innovation Listen to the AHF Podcast on your preferred platform: Buzzsprout: https://ahfpodcast.buzzsprout.com Apple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487 Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHc LinkedIn: https://www.linkedin.com/showcase/ahf-podcast YouTube: https://www.youtube.com/@anteriorhipfoundation Homepage: https://anteriorhipfoundation.com This podcast is intended for educational and informational purposes only. The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion. #AnteriorHipFoundation #AHFPodcast #AlexanderSah #SurgeonInnovator #MedicalDeviceDevelopment #ThinkSurgical #Ospitek #OrthopaedicInnovation #JointReplacement #HipAndKneeSurgery #AIinSurgery #FromIdeaToMarket #MedTech #SurgicalRobotics

  8. May 15

    From Idea to Market: Ep 9 - Inside the Decision Room

    Send us Fan Mail What med tech investors and strategic acquirers actually evaluate when a founder walks into the room — and what separates the pitches that earn capital from those that don't. A conversation drawn from people who've sat on both sides of the table. For nine episodes, the From Idea to Market series has followed innovation from the founder's perspective — the problem noticed in a clinic, the iteration through years of prototypes, the regulatory climb, the manufacturing scale-up. Episode nine flips the lens. For the first time, the conversation moves into the room where decisions about that founder get made: by investors, by strategic acquirers, by the people whose capital and reputation come along with a yes. Joe Schwab is joined by voices who've lived this evaluation from every side. Charles Lawrie is a co-founder and chief medical officer at FIOS Health and the current president of the Anterior Hip Foundation. Charlie DeCook is the president of Total Joint Specialists and has watched dozens of Shark Tank pitches at AHF annual meetings. Alex Sah is past AHF president, chief medical officer at Think! Surgical, and chief innovation officer at Ospitek. Robert Cohen, vice president of innovation and technology for Stryker's orthopaedic group, has spent four decades evaluating med tech ideas from inside startups and from inside one of the largest companies in the field. The episode unpacks three questions: what truly drives the decisions made behind closed doors, how clinical value and financial logic and strategic interest actually intersect in real time, and which kinds of narrative survive due diligence — and which collapse the moment scrutiny begins. For surgeon-founders preparing to pitch, for clinicians thinking about their first innovation, and for anyone curious about how med tech capital actually gets allocated, this episode lays out what the decision room is really testing. ⏱️ Chapters: 00:00 Why this episode flips perspective from founder to investor 02:42 Surgeons and industry leaders inside the med tech decision room 04:46 What investors actually look for in a med tech pitch 08:23 How to structure a 15-minute med tech pitch 13:30 Where clinical value, profit, and strategy intersect 15:30 Why a great med tech idea can fail to scale 18:36 Why founders should pitch with a CEO at their side 22:02 How honest narrative wins under due diligence scrutiny 26:40 Stick to your competency: advice from a Stryker VP 29:12 What the decision room is really testing 31:43 Preview: when scaling success threatens to break the company Listen to the AHF Podcast on your preferred platform: Buzzsprout: https://ahfpodcast.buzzsprout.com Apple Podcasts: https://podcasts.apple.com/us/podcast/ahf-podcast/id1749521487 Spotify: https://open.spotify.com/show/5CrGJyvRiQFTCU3FFFVvHc LinkedIn: https://www.linkedin.com/showcase/ahf-podcast YouTube: https://www.youtube.com/@anteriorhipfoundation Homepage: https://anteriorhipfoundation.com This podcast is intended for educational and informational purposes only. The content discussed does not constitute medical advice and should not be used as a substitute for professional judgment. Clinicians should rely on their own training, experience, and clinical decision-making when applying information from this discussion. #AnteriorHipFoundation #AHFPodcast #MedTech #MedTechInnovation #FromIdeaToMarket #MedicalDevices #MedTechInvesting #OrthopedicSurgery #StartupPitch #VentureCapital #Stryker #SharkTank

Trailers

Ratings & Reviews

5
out of 5
5 Ratings

About

The AHF Podcast features thoughtful conversations about orthopedic surgery, outcomes, and clinical decision-making, with a particular focus on hip surgery and related innovation.Produced by the Anterior Hip Foundation, the podcast brings together surgeons, researchers, and clinical leaders to examine how evidence, experience, and real-world practice intersect. Episodes explore what the data actually shows, where assumptions break down, and how clinicians navigate uncertainty in daily practice.This podcast is intended for orthopedic surgeons, trainees, and medically literate clinicians who value nuanced discussion, critical thinking, and honest examination of what improves patient care.